Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Cetuximab × Clear all

NCT00728663 2019-05-14

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms